Detalhe da pesquisa
1.
Development of a novel immunoFET technology-based POC assay for detection of Leishmania donovani and Leishmania major.
Parasite Immunol
; 45(7): e12984, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183939
2.
The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of Leishmania major.
J Immunol
; 206(5): 1013-1026, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462138
3.
Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
J Clin Microbiol
; 60(1): e0171721, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669455
4.
Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts.
Trop Med Int Health
; 24(2): 192-204, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30565348
5.
Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
BMC Infect Dis
; 18(1): 500, 2018 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285653
6.
Genetic analysis of Leishmania donovani tropism using a naturally attenuated cutaneous strain.
PLoS Pathog
; 10(7): e1004244, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992200
7.
Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal.
BMC Infect Dis
; 16(1): 539, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716091
8.
Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.
J Proteome Res
; 14(2): 1033-59, 2015 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25536015
9.
Determinants for the development of visceral leishmaniasis disease.
PLoS Pathog
; 9(1): e1003053, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23300451
10.
A2 and other visceralizing proteins of Leishmania: role in pathogenesis and application for vaccine development.
Subcell Biochem
; 74: 77-101, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24264241
11.
Role of cytosolic glyceraldehyde-3-phosphate dehydrogenase in visceral organ infection by Leishmania donovani.
Eukaryot Cell
; 12(1): 70-7, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23125352
12.
Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh.
Emerg Infect Dis
; 19(7): 1131-4, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23764246
13.
Vaccine value profile for leishmaniasis.
Vaccine
; 41 Suppl 2: S153-S175, 2023 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951693
14.
Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes.
iScience
; 26(9): 107594, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744404
15.
Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response.
iScience
; 26(9): 107593, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37744403
16.
Long-Term Efficacy of Insecticidal Wall Painting for Controlling Visceral Leishmaniasis Vectors in Bangladesh.
Am J Trop Med Hyg
; 109(5): 1022-1027, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722667
17.
Leishmania donovani persistence and circulation causing cutaneous leishmaniasis in unusual-foci of Nepal.
Sci Rep
; 13(1): 12329, 2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516780
18.
Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field.
Nat Commun
; 14(1): 7028, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919280
19.
Involvement of the Leishmania donovani virulence factor A2 in protection against heat and oxidative stress.
Exp Parasitol
; 132(2): 109-15, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22691540
20.
Investigation of Visceral LeishmaniasisTransmission in Selected Districts of Nepal.
J Nepal Health Res Counc
; 20(1): 194-201, 2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945875